Anti-Adhesion Product
Phase 2Completed 0 watching 0 views this week⚡ Active
49
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Intraperitoneal Adhesions
Conditions
Intraperitoneal Adhesions
Trial Timeline
Dec 1, 2000 → Apr 1, 2003
NCT ID
NCT00512356About Anti-Adhesion Product
Anti-Adhesion Product is a phase 2 stage product being developed by Baxter for Intraperitoneal Adhesions. The current trial status is completed. This product is registered under clinical trial identifier NCT00512356. Target conditions include Intraperitoneal Adhesions.
Hype Score Breakdown
Clinical
17
Activity
12
Company
7
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00512356 | Phase 2 | Completed |